Acadia Pharmaceuticals (NASDAQ: ACAD) net income
Acadia Pharmaceuticals reported a net profit of $391.0m for fiscal 2025, 72.7% more than in fiscal 2024 ($226.5m). Its net margin was 36.5%. Earnings per share were $2.32.
Fiscal 2025 is the highest of the 10 fiscal years on record for Acadia Pharmaceuticals. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $391.0m | +72.7% | 36.5% | $2.32 |
| 2024 | $226.5m | — | 23.6% | $1.37 |
| 2023 | −$61.3m | — | −8.4% | −$0.37 |
| 2022 | −$216.0m | — | −41.8% | −$1.34 |
| 2021 | −$167.9m | — | −34.7% | −$1.05 |
| 2020 | −$281.6m | — | −63.7% | −$1.79 |
| 2019 | −$235.3m | — | −69.4% | — |
| 2018 | −$245.2m | — | −109.6% | — |
| 2017 | −$289.4m | — | −231.7% | — |
| 2016 | −$271.4m | — | −1,565.9% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Acadia Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, Acadia Pharmaceuticals ranks 68th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Acadia Pharmaceuticals, 36.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 66th | Henry Schein | $398.0m | 3.0% |
| 67th | AptarGroup | $392.8m | 10.4% |
| 68th | Acadia Pharmaceuticals | $391.0m | 36.5% |
| 69th | Cooper Companies | $374.9m | 9.2% |
| 70th | Rigel Pharmaceuticals | $367.0m | 124.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Acadia Pharmaceuticals
- How much did Acadia Pharmaceuticals earn in fiscal 2025?
- Acadia Pharmaceuticals reported a net profit of $391.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $226.5m.
- What are the earnings per share of Acadia Pharmaceuticals?
- They were $2.32 in fiscal 2025, compared with $1.37 in fiscal 2024.
- What is the net margin of Acadia Pharmaceuticals?
- In fiscal 2025 its net profit was 36.5% of its revenue.
- What was the most profitable year for Acadia Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2025, with $391.0m.
- Where does Acadia Pharmaceuticals rank in its sector by net income?
- It ranks 68th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Acadia Pharmaceuticals come from?
- From the annual report (Form 10-K) that Acadia Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Acadia Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Acadia Pharmaceuticals: the Acadia Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.